Michael R. Briggs
32 works · 7,423 citations · h-index 20
Top works
- Purification and Biochemical Characterization of the Promoter-Specific Transcription Factor, Sp1
- SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
- SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.
- PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.
- Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence
- Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization
- The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
- Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism
- Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates
- Identification of DNA sequences required for mouse APRT gene expression
- HDL: The Metabolism, Function, and Therapeutic Importance
- Identification of a Novel Sterol-independent Regulatory Element in the Human Low Density Lipoprotein Receptor Promoter
- Induction of LPL gene expression by sterols is mediated by a sterol regulatory element and is independent of the presence of multiple E boxes
- Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes
- Requirement of Sp1 and Estrogen Receptor α Interaction in 17β-Estradiol-Mediated Transcriptional Activation of the Low Density Lipoprotein Receptor Gene Expression*
- Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M
- Regulation of OB Gene Expression in Rodents and Humans
- Utilization of Recombinant Adenovirus and Dominant Negative Mutants to Characterize Hepatocyte Nuclear Factor 4-regulated Apolipoprotein AI and CIII Expression
- Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M
- Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase